<?xml version="1.0" encoding="ISO-8859-15" ?> 
<?xml-stylesheet title="XSL_formatting" type="text/xsl" href="/rss/rss.xsl" ?> 
<rss version="2.0" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">

<channel>

<title>PCRonline: Press Releases</title>
<link>http://www.pcronline.com</link>
<description>The online source of education in the field of interventional cardiology and radiology</description>
<copyright>Copyright PCRonline.com</copyright>
<image>
<url>http://www.pcronline.com/images/logos/pcronline_100.gif</url>
<title>PCRonline: Press Releases</title>
<link>http://www.pcronline.com</link>
</image>
<category>Press Releases</category>
<ttl>20</ttl>
<pubDate>Mon, 10 May 2010 12:26:10 +0200</pubDate>

<item>
<title>ABBOTT &amp;ndash; Separate, Retrospective SPIRIT IV Cost-Effectiveness Analysis Presented Earlier this Year Concludes XIENCE V Is Economically Dominant Compared to TAXUS
</title>
<description>ABBOTT PARK, Ill., May 5, 2010 --Findings from Abbott's SPIRIT IV trial, one of the largest randomized clinical trials comparing two drug eluting stents, with 3,690 U.S.-based patients, were published today in The New England Journal of Medicine. The published study results show that one year after ...</description>
<link>http://www.pcronline.com/fo/exchange/news/press_releases.php?news_id=3264</link>
<guid>http://www.pcronline.com/fo/exchange/news/press_releases.php?news_id=3264</guid>
</item>

<item>
<title>SORIN GROUP Announces Distribution Agreement with Cardiomedical Gmbh for Cardio Visiontm Range of Minimally Invasive Surgical Instruments</title>
<description>Agreement adds new product line to Sorin core Heart Valves business  franchise
Milan, Italy May 3, 2010 &amp;amp;ndash; Sorin Group, a global company and a leader in the treatment of  cardiovascular diseases, announced today that it has entered into a  distribution agreement, effective May 1, 2010,...</description>
<link>http://www.pcronline.com/fo/exchange/news/press_releases.php?news_id=3262</link>
<guid>http://www.pcronline.com/fo/exchange/news/press_releases.php?news_id=3262</guid>
</item>

<item>
<title>MILLENNIUM RESEARCH GROUP &amp;ndash; Acquisition of ATS Medical Will Increase Medtronic&amp;rsquo;s Share in the Heart Valve and Surgical Ablation Markets, According to Millennium Research Group
</title>
<description>May 4,  2010&amp;amp;mdash;Waltham, Massachusetts&amp;amp;mdash; According to Millennium Research  Group (MRG), the global authority on medical technology market  intelligence, Medtronic could see its heart valve and surgical ablation  market shares increase if the company completes its recently ann...</description>
<link>http://www.pcronline.com/fo/exchange/news/press_releases.php?news_id=3263</link>
<guid>http://www.pcronline.com/fo/exchange/news/press_releases.php?news_id=3263</guid>
</item>

<item>
<title>MEDTRONIC Signs Agreement to Acquire ATS Medical 
</title>
<description> Acquisition Will Expand Access to Innovative  Treatment Options for Structural Heart Disease 
MINNEAPOLIS &amp;amp;ndash; April 29, 2010 &amp;amp;ndash;  Medtronic, Inc. (NYSE: MDT), and ATS Medical, Inc. (NASDAQ: ATSI), today  announced that the companies have signed a definitive agreement under ...</description>
<link>http://www.pcronline.com/fo/exchange/news/press_releases.php?news_id=3259</link>
<guid>http://www.pcronline.com/fo/exchange/news/press_releases.php?news_id=3259</guid>
</item>

<item>
<title>ORBUSNEICH's Genous&amp;trade; Bio-engineered R stent&amp;trade; Demonstrates Excellent Safety and Clinical Outcomes in High-Risk Elderly Patients
</title>
<description>Clinical Data Presented at Angioplasty Summit Transcatheter Cardiovascular Therapeutics Conference Asia Pacific 2010 in Seoul, South Korea
SEOUL, South Korea, April 29, 2010 &amp;amp;ndash; OrbusNeich today announced that a subset analysis of patients over 70 years of age in the final 12-month clin...</description>
<link>http://www.pcronline.com/fo/exchange/news/press_releases.php?news_id=3258</link>
<guid>http://www.pcronline.com/fo/exchange/news/press_releases.php?news_id=3258</guid>
</item>

<item>
<title>CELLADON CORP. Announces that MYDICAR® Meets Primary Endpoint in Phase 2 Trial for Treatment of Advanced Heart Failure
</title>
<description>Study Results Demonstrate Favorable Treatment  Effects  with Genetically Targeted Enzyme Replacement Therapy
LA JOLLA, Calif., April 28, 2010 &amp;amp;ndash; Celladon Corp., a   biopharmaceutical company focused on the discovery and development of   innovative treatments for cardiovascular diseases...</description>
<link>http://www.pcronline.com/fo/exchange/news/press_releases.php?news_id=3261</link>
<guid>http://www.pcronline.com/fo/exchange/news/press_releases.php?news_id=3261</guid>
</item>

<item>
<title>MEDTRONIC &amp;ndash; Physio-Control Launches Version 4.1 of Its LIFENET® System
</title>
<description> First-To-Market Feature Allows Integration  of Data from Multiple Vendors&amp;amp;rsquo; 12-lead Management Systems 
REDMOND, WASH.  &amp;amp;ndash; April 27, 2010 &amp;amp;ndash; Physio-Control, Inc., a wholly-owned  subsidiary of Medtronic, Inc., today announced the launch  of Version 4.1 of its...</description>
<link>http://www.pcronline.com/fo/exchange/news/press_releases.php?news_id=3257</link>
<guid>http://www.pcronline.com/fo/exchange/news/press_releases.php?news_id=3257</guid>
</item>

<item>
<title>VOLCANO Announces Distribution Agreement With AngioScore for the AngioSculpt(R) PTCA Scoring Balloon Catheter in Japan
</title>
<description>Volcano continues to expand suite of devices that include both PCI  guidance and therapy 
SAN DIEGO, April 27, 2010 /PRNewswire via COMTEX News  Network/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and  manufacturer of precision intravascular therapy guidance tools designed  to enhan...</description>
<link>http://www.pcronline.com/fo/exchange/news/press_releases.php?news_id=3256</link>
<guid>http://www.pcronline.com/fo/exchange/news/press_releases.php?news_id=3256</guid>
</item>

<item>
<title>EDWARDS LIFESCIENCES &amp;ndash; First Transcatheter Valve Clinical Trial in Japan Treats Patients With Edwards SAPIEN XT Valve 
</title>
<description>IRVINE, CA, April 26, 2010 --  Edwards Lifesciences  Corporation, the global leader in the science of heart valves  and hemodynamic monitoring, today announced that it has begun enrolling  patients in Japan's first clinical trial studying transcatheter aortic  heart valves. Utilizing the recently CE...</description>
<link>http://www.pcronline.com/fo/exchange/news/press_releases.php?news_id=3255</link>
<guid>http://www.pcronline.com/fo/exchange/news/press_releases.php?news_id=3255</guid>
</item>

<item>
<title>TRYTON Launches Side-Branch Stent in Eleven European Countries
</title>
<description>More than 1,000 Patients Treated with Tryton System



Research  Triangle Park, N. C. and Brussels &amp;amp;ndash; April 22, 2010 &amp;amp;ndash; Tryton  Medical, Inc., the leading developer of stents designed to definitively  treat bifurcation lesions, today announced the launch of the TRYTON Sid...</description>
<link>http://www.pcronline.com/fo/exchange/news/press_releases.php?news_id=3253</link>
<guid>http://www.pcronline.com/fo/exchange/news/press_releases.php?news_id=3253</guid>
</item>

</channel>

</rss>